You just read:

Daiichi Sankyo Initiates Phase 3 ENSURE-AF Study, Investigating Once-Daily Edoxaban in Patients with Atrial Fibrillation Undergoing Cardioversion

News provided by

Daiichi Sankyo Company, Limited

31 Mar, 2014, 12:00 BST